Mechanisms of E3 modulation of immune and inflammatory responses

Current Topics in Microbiology and Immunology

Volumn 273, Issue , 2004, Pages 113-135

  Fessler, S P ^a   Delgado Lopez, F ^a   Horwitz, M S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CELL SURFACE RECEPTOR; CHEMOKINE; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VIRUS PROTEIN;

ADE3 TRANSGENE; ADENOVIRUS; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DIABETES MELLITUS; GENE DELETION; GENE FUNCTION; GENE THERAPY; IMMUNOMODULATION; INFLAMMATION; MOLECULAR EVOLUTION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENE; TRANSGENIC MOUSE; VIRUS SURVIVAL; VIRUS VIRULENCE;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 0141680831     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-662-05599-1_4     Document Type: Review

References (88)

1. Andersson, M., McMichael, A., and Peterson, P. A. (1987) Reduced allorecognition of adenovirus 2 infected cells. Journal of Immunology 138, 3960-3966
2. Andrade, F., Bull, H. G., Thornberry, N. A., Ketner, G. W., Casciola-Rosen, L. A., and Rosen, A. (2001) Adenovirus L4-100 K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. Immunity. 14, 751-761
3. Aradhya, S., Courtois, G., Rajkovic, A., Lewis, R., Levy, M., Israel, A., and Nelson, D. (2001) Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma) Am. J Hum. Genet. 68, 765-771
4. Basler, C. and Horwitz, M. S. (1996) Subgroup B adenovirus type 35 early region 3 mRNAs differ from those of the subgroup C adenoviruses. Virol. 216, 165-177
5. Basler, C. F., Droguett, G., and Horwitz, M. S. (1996) Sequence of the immunoregulatory early region 3 and flanking sequences of adenovirus type 35. Gene 170, 249-254
6. Beier, D. C., Cox, J. H., Vining, D. R., Cresswell, P., and Engelhard, V. H. (1994) Association of human class I MHC alleles with the adenovirus E3/19K protein. J Immunol. 152, 3862-3872
7. Benedict, C. A., Norris, P. S., Prigozy, T. I., Bodmer, J. L., Mahr, J. A., Garnett, C. T., Martinon, F., Tschopp, J., Gooding, L. R., and Ware, C. F. (2001) Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J Biol. Chem 276, 3270-3278
8. Bennett, E. M., Bennink, J. R., Yewdell, J. W., and Brodsky, F. M. (1999) Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. Journal of Immunology 162, 5049-5052
9. Bruder, J. T. and Kovesdi, I. (1997) Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol. 71, 398-404
10. Buntzman, A, Friedman, J., Fessler, S., and Horwitz, M. S. 2003. Ref Type: Unpublished Work
11. Burgert, H. G. and Blusch, J. H. (2000) Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses. Virus Genes 21, 13-25
12. Burgert, H. G. and Kvist, S. (1985) An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41, 987-997
13. Burgert, H. G., Maryanski, J. L., and Kvist, S. (1987) "E3/ 19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proceedings of the National Academy of Sciences of the United States of America 84, 1356-1360
14. Carlin, C. R., Tollefson, A. E., Brady, H. A., Hoffman, B. L., and Wold, W. S. M. (1989) Epidermal growth factor receptor is down-regulated by a 10,400 mw protein encoded by the E3 region of adenovirus. Cell 57, 135-144
15. Chen, P., Tian, J., Kovesdi, I., and Bruder, J. T. (1998) Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis. Journal of Biological Chemistry 273, 5815-5820
16. Deryckere, F. and Burgert, H. G. (1996) Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C. Journal of Virology 70, 2832-2841
17. Dimitrov T, Krajcsi P, Hermiston TW, Tollefson AE, Hannink M, a., and Wold W.S.M. (1997) Adenovirus E3-10.4/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. Journal of Virology 71, 2830-2837
18. Driesse, M. J., Esandi, M. C., Kros, J. M., Avezaat, C. J., Vecht, C., Zurcher, C., van, d. V., I, Valerio, D., Bout, A., and Sillevis Smitt, P. A. (2000) Intra-CSF administered recombinant adenovirus causes an immune response- mediated toxicity. Gene Ther. 7, 1401-1409
19. Dufke, A., Vollmer, B., Kendziorra, H., Mackensen-Haen, S., Orth, U., Orlikowsky, T., and Gal, A. (2001) Hydrops fetalis in three male fetuses of a female with incontinentia pigmenti. Prenat. Diagn. 21, 1019-1021
20. Efrat, S., Fejer, G., Brownlee, M., and Horwitz, M. S. (1995) Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proceedings of the National Academy of Sciences of the United States of America 92, 6947-6951
21. Efrat, S., Serreze, D. V., Svetlanov, A., Post, C. M., Johnson, E. A., Herold, K., and Horwitz M.S. (2001) Adenovirus early region 3 (E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in nonobese diabetic (NOD) mice. Diabetes 50, 980-984
22. Elsing, A. and Burgert, H. G. (1998) The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc.-Natl. Acad. Sci. U.S.A 95, 10072-10077
23. Fessler, S. and Horwitz M.S. 2003 Ref Type: Unpublished Work
24. Flomenberg, P., Babbitt, J., Drobyski, W. R., Ash, R. C., Carrigan, D. R., Sedmak, G. V., McAuliffe, T., Camitta, B., Horowitz, M. M., Bunin, N., and Casper, J. T. (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. Journal of Infectious Diseases 169, 775-781
25. Flomenberg, P., Piaskowski, V., Truitt, R. L., and Casper, J. T. (1996) Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol. 70, 6314-6322
26. Friedman, J. M. and Horwitz, M. S. (2002) Inhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex. J Virol. 76, 5515-5521
27. Funk, C. D. (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875
28. Ginsberg, H. S., Lundholm-Beauchamp, U., Horswood, R. L., Pernis, B., Wold, W. S. M., Chanock, R. M., and Prince, G. A. (1989) Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proceedings of the National Academy of Sciences of the United States of America 86, 3823-3827
29. Gooding, L. R., Ranheim, T. S., Tollefson, A. E., Aquino, L., Duerksen-Hughes, P. J., Horton, T. M., and Wold, W. S. M. (1991) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. Journal of Virology 65(8), 4114-4123
30. Gooding, L. R., Sofola, I. O., Tollefson, A. E., Duerksen-Hughes, P. J., and Wold, W. S. M. (1990) The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. Journal of Immunology 145, 3080-3086
31. Hattula, K. and Peranen, J. (2000) FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr. Biol. 10, 1603-1606
32. Hirose, E., Nakashima, N., Sekiguchi, T., and Nishimoto, T. (1998) RagA is a functional homologue of S. cerevisiae Gtr1p involved in the Ran/ Gsp1-GTPase pathway. J. Cell Sci. 111, 11-21
33. Hitt, M. M. and Graham, F. L. (2000) Adenovirus vectors for human gene therapy. Adv. Virus Res. 55, 479-505
34. Hoffman, P., Yaffe, M. B., Hoffman, B. L., Yei, S., Wold, W. S. M., and Carlin, C. R. (1992) Characterization of the adenovirus E3 protein that down-regulates the epidermal growth factor receptor. Journal of Biological Chemistry 267(19), 13480-13487
35. Horton, T. M., Ranheim, T. S., Aquino, L., Kusher, D. I., Saha, S. K., Ware, C. F., Wold, W. S. M., and Gooding, L. R. (1991) Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. Journal of Virology 65(5), 2629-2639
36. Horton, T. M., Tollefson, A. E., Wold, W. S. M., and Gooding, L. R. (1990) A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes. Journal of Virology 64(3), 1250-1255
37. Horwitz M.S. (2001) Adenoviruses. In "Fields Virology" (D. M. Knipe and P. M. Howley, Eds.), pp. 2301-2326. Lippincott-Williams and Wilkins
38. Horwitz, M. S. (2001) Adenovirus immunoregulatory genes and their cellular targets. Virology 279, 1-8
39. Jain, A., Ma, C. A., Liu, S., Brown, M., Cohen, J., and Strober, W. (2001) Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat.Immunol. 2, 223-228
40. Kim, H. J. and Foster, M. P. (2002) Characterization of Ad5 E3-14.7K, an adenoviral inhibitor of apoptosis: structure, oligomeric state, and metal binding. Protein Sci. 11, 1117-1128
41. Kirchhausen, T. (1999) Adaptors for clathrin-mediated traffic. Annu. Rev. Cell Dev.-Biol. 15, 705-732
42. Kojaoghlanian, T., Flomenberg, P., and Horwitz M.S. (2003) The Impact of Adenovirus Infection on the Immunocompromised Host. Reviews in Medical Virology 76, 8236-8243
43. Korner, H. and Burgert, H. G. (1994) Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. Journal of Virology 68, 1442-1448
44. cyt orientation. Virology 187, 131-144
45. Krajcsi, P., Tollefson, A. E., Anderson, C. W., and Wold, W. S. M. (1992b) The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. Journal of Virology 66(3), 1665-1673
46. Krajcsi, P., Tollefson, A. E., and Wold, W. S. M. (1992c) The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylated. Virology 188, 570-579
47. Krajcsi, P. and Wold, W. S. M. (1992) The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine. Virology 187, 492-498
48. Leland, B. J. and Metcalf, J. P. (1999) Type-specific induction of interleukin-8 by adenovirus. Am. J Respir. Cell Mol. Biol. 21, 521-527
49. Lesokhin, A. M., Delgado-Lopez, F., and Horwitz, M. S. (2002) Inhibition of chemokine expression by adenovirus early region three (e3) genes. J Virol. 76, 8236-8243
50. Li, Y. Identification and characterization of cellular proteins which interact with adenovirus E3-14.7kDA protein, an antagonist of TNF-alpha. 1996. Albert Einstein College of Medicine (thesis for Ph.D. degree)
51. Li, Y., Kang, J., Friedman, J., Tarassishin, L., Ye, J., Kovalenko, A., Wallach, D., and Horwitz, M. S. (1999) Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A 96, 1042-1047
52. Li, Y., Kang, J., and Horwitz M.S. (1998) Interaction of an adenovirus E3-14.7 kDa protein with a novel TNF-alpha inducible cellular protein containing leucine zipper domains. Mol. Cell. Biol. 18, 1601-1610
53. Li, Y., Kang, J., and Horwitz, M. S. (1997) Interaction of an adenovirus 14.7 kDa protein inhibitor of TNF-alpha cytolysis with a new member of the GTPase super-family of signal transducers. Journal of Virology 71, 1576-1582
54. Lichtenstein, D. L., Krajcsi, P., Esteban, D. J., Tollefson, A. E., and Wold, W. S. (2002) Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis. J Virol. 76, 11329-11342
55. Lukashok, S. A., Tarassishin, L., Li, Y., and Horwitz, M. S. (2000) An adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis complexes with dynein and a small GTPase. Journal of Virology 74, 4705-4709
56. Mahr, J. A., Boss, J. M., and Gooding, L. R. (2003) The adenovirus e3 promoter is sensitive to activation signals in human T cells. J Virol. 77, 1112-1119
57. McNees, A. L., Garnett, C. T., and Gooding, L. R. (2002) The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis. J Virol. 76, 9716-9723
58. Mercurio, F., Murray, B. W., Shevchenko, A., Bennett, B. L., Young, D. B., Li, J. W., Pascual, G., Motiwala, A., Zhu, H., Mann, M., and Manning, A. M. (1999) IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell Biol. 19, 1526-1538
59. Moreland, R. J., Dresser, M. E., Rodgers, J. S., Roe, B. A., Conaway, J. W., Conaway, R. C., and Hanas, J. S. (2000) Identification of a transcription factor IIIA-interacting protein. Nucleic Acids Res. 28, 1986-1993
60. Muruve, D. A., Barnes, M. J., Stillman, I. E., and Libermann, T. A. (1999) Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10, 965-976
61. Nakashima, N., Hayashi, N., Noguchi, E., and Nishimoto, T. (1996) Putative GTPase Gtr1p genetically interacts with the RanGTPase cycle in Saccharomyces cerevisiae. Cell Sci. 109 (Pt 9), 2311-2318
62. Nakashima, N., Noguchi, E., and Nishimoto, T. (1999) Saccharomyces cerevisiae putative G protein, Gtr1p, which forms complexes with itself and a novel protein designated as Gtr2p, negatively regulates the Ran/Gsp1p G protein cycle through Gtr2p. Genetics 152, 853-867
63. Orange, J. S., Brodeur, S. R., Jain, A., Bonilla, F. A., Schneider, L. C., Kretschmer, R., Nurko, S., Rasmussen, W. L., Kohler, J. R., Gellis, S. E., Ferguson, B. M., Strominger, J. L., Zonana, J., Ramesh, N., Ballas, Z. K., and Geha, R. S. (2002) Deficient natural killer cell cytotoxicity in patients with IKK- gamma/NEMO mutations. J Clin. Invest 109, 1501-1509
64. Pierce, M. A., Chapman, H. D., Post, C. M., Svetlanov, A., Efrat, S., Horwitz M.S., and Serreze, D. V. (2003) Adenovirus early region 3 antiapoptotic 10.4K, 14.5K, and 14.7K genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 52(5) 1119-1127
65. Ranheim, T. S., Shisler, J., Horton, T. M., Wold, L. J., Gooding, L. R., and Wold, W. S. M. (1993) Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. Journal of Virology 67(4), 2159-2167
66. Rawle, F. C., Knowles, B. B., Ricciardi, R. P., Brahmacheri, V., Duerksen-Hughes, P., Wold, W. S. M., and Gooding, L. R. (1991) Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. Journal of Immunology 146, 3977-3984
67. Rezaie, T., Child, A., Hitchings, R., Brice, G., Miller, L., Coca-Prados, M., Heon, E., Krupin, T., Ritch, R., Kreutzer, D., Crick, R. P., and Sarfarazi, M. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295, 1077-1079
68. Rothwarf, D. M., Zandi, E., Natoli, G., and Karin, M. (1998) IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395, 297-300
69. Roy-Chowdhury, J. and Horwitz M.S. (2002) Evolution of Adenoviruses as Gene Therapy Vectors. Molecular Therapy 5, 344
70. Schurmann, A., Brauers, A., Mabmann, S., Becker, W., and Joost, H. G. (1995) Cloning of a novel family of mammalian GTP-binding proteins (RagA, RagBs, RagB1) with remote similarity to the Ras-related GTPases. Journal of Biological Chemistry 270, 28982-28988
71. Schwamborn, K., Weil, R., Courtois, G., Whiteside, S. T., and Israel, A. (2000) Phorbol esters and cytokines regulate the expression of the NEMO- related protein, a molecule involved in a NF-kappa B-independent pathway. Journal of Biological Chemistry 275, 22780-22789
72. Sekiguchi, T., Hirose, E., Nakashima, N., Ii, M., and Nishimoto, T. (2001) Novel g proteins, rag c and rag d, interact with gtp-binding proteins, rag a and rag b. J Biol. Chem 276, 7246-7257
73. Shisler, J., Yang, C., Walter, B., Ware, C. E, and Gooding, L. R. (1997) The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. Journal of Virology 71, 8299-8306
74. Stewart, A. R., Tollefson, A. E., Krajcsi, P., Yei, S. P., and Wold, W. S. M. (1995) The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane. Journal of Virology 69, 172-181
75. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D. R., Aebersold, R., Siderovski, D. P., Penninger, J. M., and Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446
76. Tarassishin, L. and Horwitz, M. S. (2001) Sites on FIP-3 (NEMO/IKKgamma) essential for its phosphorylation and NF- kappaB modulating activity. Biochem. Biophys. Res. Commun. 285, 555-560
77. Tollefson, A. E., Hermiston, T. W., Lichtenstein, D. L., Colle, C. F., Tripp, R. A., Dimitrov, T., Toth, K., Wells, C. E., Doherty, P. C., and Wold, W. S. (1998) Forced degradation of Fas inhibits apoptosis in adenovirus- infected cells. Nature 392, 726-730
78. Tollefson, A. E., Ryerse, J. S., Scaria, A., Hermiston, T. W., and Wold, W. S. (1996) The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. Virology 220, 152-162
79. Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., and Wold, W. S. M. (1996) The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. Journal of Virology 70, 2296-2306
80. Tollefson, A. E., Toth, K., Doronin, K., Kuppuswamy, M., Doronina, O. A., Lichtenstein, D. L., Hermiston, T. W., Smith, C. A., and Wold, W. S. (2001) Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J Virol. 75, 8875-8887
81. von Herrath, M., Efrat, S., Oldstone, M. B. A., and Horwitz, M. S. (1997) Expression of adenoviral E3 transgenes in β cells prevents autoimmune diabetes. Proceedings of the National Academy of Sciences of the United States of America 94, 9808-9813
82. Wen, S., Driscoll, R. M., Schneider, D. B., and Dichek, D. A. (2001) Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transfer. Arterioscler. Thromb. Vasc. Biol. 21, 1777-1782
83. Wilmott, R. W., Amin, R. S., Perez, C. R., Wert, S. E., Keller, G., Boivin, G. P., Hirsch, R., De Inocencio, J., Lu, P., Reising, S. F., Yei, S., Whitsett, J. A., and Trapnell, B. C. (1996) Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. Hum. Gene Ther. 7, 301-318
84. Wold, W. S., Doronin, K., Toth, K., Kuppuswamy, M., Lichtenstein, D. L., and Tollefson, A. E. (1999) Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Curr. Opin. Immunol. 11, 380-386
85. Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., and Israel, A. (1998) Complementation Cloning of Nemo, a Component of the lkB Kinase Complex Essential for NF-kB Activation. Cell 93, 1231-1240
86. Ye, J., Xie, X., Tarassishin, L., and Horwitz, M. S. (2000) Regulation of the NF-kappaB activation pathway by isolated domains of FIP3/IKKgamma, a component of the IkappaB-alpha kinase complex. Journal of Biological Chemistry 275, 9882-9889
87. Zilli, D., Voelkel-Johnson, C., Skinner, T., and Laster, S. M. (1992) The adenovirus E3 region 14.7 kDa protein, heat and sodium arsinate inhibit the TNF-induced release of arachidonic acid. Biochemical and Biophysical Research Communications 188, 177-183
88. Zonana, J., Elder, M. E., Schneider, L. C., Orlow, S. J., Moss, C., Golabi, M., Shapira, S. K., Farndon, P. A., Wara, D. W., Emmal, S. A., and Ferguson, B. M. (2000) A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO) Am. J Hum. Genet. 67, 1555-1562